Impact of Daratumumab
20 September 2017 01:30pm - 02:00pm - Australia/Sydney
Investigate the challenges faced by a transfusion laboratory as they perform pre-transfusion testing to find compatible blood for multiple myeloma patients undergoing Daratumumab therapy and how these issues can be resolved.
- Describe the impacts of Daratumumab on pre-transfusion testing and investigation processes.
- Improve awareness of the key challenges faced by a transfusion laboratory when providing compatible blood for multiple myeloma patients
|Presenters: Ms Kerman Buhariwala, Medical Scientist, Clinical Services and Research, Blood Service.|